KRRO Korro Bio, Inc: Net earnings per share growth forecast for next year
Korro Bio, Inc. (KRRO) is minimizing patent risks by diversifying its early-stage RNA editing developments. The forward-looking earnings per share growth forecast visualizes these expectations, where the 1.80 indicator expresses the state of the metric. Future revenues are tied to the correction of genetic defects, while the current strategy focuses on moving the lead liver candidate into the clinic.
Analytical breakdowns for Korro Bio (KRRO)
- share price and consensus valuation forecast:
- company stock capitalization data:
- company book value details:
- issuer credit burden and liquidity indicators:
- earnings and market ratios statistics:
KRRO - Final Profit|Expected Profit Korro Bio, Inc.|KRRO - Company Value to Net Income|Future Price to Earnings Korro Bio Inc.|KRRO - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple Korro Bio|KRRO - Operating profit before amortization|Earnings per share for the last twelve months Korro Bio|KRRO - Earnings per share for the last 12 months|Quarterly EPS earnings growth korrobio.com|KRRO - Earnings growth in current year|Net earnings per share growth forecast for next year Korro Bio, Inc.
Comprehensive company analysis:Korro Bio, Inc.
This indicator reflects the analysts' consensus forecast for the change in earnings per share for the coming year. This projection of the company's earnings dynamics for next year visualizes market expectations regarding the growth or contraction rates of net income. The metric measures fundamental value potential through the ratio of future earnings to the number of shares. For Korro Bio, Inc. (KRRO), negative operating leverage during the R&D stage makes this figure an indicator of the capital burn rate while scaling the platform.
Competitor analysis
TEM (Tempus AI, Inc) - Earnings growth forecast for next year|Qiagen Corp (QGEN) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Ionis Pharmaceuticals (IONS)|RGEN - Expected net earnings per share growth next year|Avidity Biosciences, Inc. - Expected earnings per share growth for next year|Expected earnings per share trend next year CRSP|Sema4 - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Ultragenyx Corp RARE|Beam Therapeutics Inc. (BEAM) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year SRPT|TWST (Twist Bioscience, Inc.) - Earnings growth forecast for next year|Expected earnings per share growth for next year 10x Genomics Inc (TXG)|Expected earnings per share growth for next year NTLA (Intellia)|Consensus forecast of earnings per share growth for next year Stoke Corp|Net earnings per share growth forecast for next year BioLife Solutions, Inc. BLFS|Earnings growth forecast for next year wavelifesciences.com WVE|MAZE - Net earnings per share growth forecast for next year|Expected earnings per share trend next year SION (Sionna Therapeutics, Inc.)|Prime Medicine Corp (PRME) - Net earnings per share growth forecast for next year|Taysha Corp - Expected earnings per share trend next year|Net earnings per share growth forecast for next year uniQure N.V.|Expected net earnings per share growth next year meiragtx.com MGTX|Earnings growth forecast for next year RGNX|Solid Biosciences Inc - Projected earnings per share growth rate for next year|Net earnings per share growth forecast for next year Ocugen Corp OCGN|PACB: Projected earnings per share growth rate for next year|Benitec Biopharma Inc. - Earnings growth forecast for next year|DSGN - Earnings growth forecast for next year|Rocket Pharmaceuticals, Inc. (RCKT) - Net earnings per share growth forecast for next year|4DMT (FDMT) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Lexeo Therapeutics Inc.|Expected net earnings per share growth next year Editas Corp EDIT|Net earnings per share growth forecast for next year Silence Therapeutics (SLN)|PRQR (proqr.com) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Codexis CDXS|Expected earnings per share trend next year SGMO|NAUT - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Metagenomi Therapeutics|DTIL (Precision BioSciences, Inc.) - Expected earnings per share growth for next year|Generation Bio - Expected earnings per share trend next year|BOLD (Boundless Bio) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year XCUR|Earnings growth forecast for next year IMNN|Consensus forecast of earnings per share growth for next year phiopharma.com|Net earnings per share growth forecast for next year Mustang Bio MBIO|TransCode Therapeutics Inc. (RNAZ) - Expected net earnings per share growth next year|BNGO: Expected earnings per share growth for next year|Expected earnings per share trend next year APDN (Applied DNA Sciences Inc)|BLUE: Earnings growth forecast for next year|IPA - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Omega Therapeutics|Projected earnings per share growth rate for next year OMIC (singulargenomics.com)|Earnings growth forecast for next year RGLS|Expected earnings per share growth for next year Syros Pharmaceuticals Inc. SYRS|Codex DNA - Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year TRACON Pharmaceuticals, Inc (TCON)|UBX - Net earnings per share growth forecast for next year
